Feb 11 – International Day of Women & Girls in Science! 🚀 At #RC2NB & @ThINk_Basel , this day is every day. Leading the way? Prof. Cristina Granziera, championing brilliant women who shape the future of #STEM.🔬💡 #WomenInScience #IDWGS #MSresearch

@RC2NB joined the MS State of the Art Symposium 2025 on "Lifestyle in MS: Sports, Nutrition, & Brain Health." Proud to see @ThINk_Basel & @JensKuhle represent RC2NB, with our team sharing research on: 🔬 MultiSCRIPT 🔬 Complement activation in MS 🔬 B cell therapies

🧠 This Saturday, Jan 25, join the Swiss MS Society’s State of the Art Symposium 2025: "Lifestyle in MS – Modifiable Factors to Enhance Brain Health." 📍 KKL Luzern ⏰ 09:30 – 16:00 Join our team and many other experts!

🚨 New in Nature Reviews Neurology! 🎉 AHSCT for MS & NMOSD gets key insights from ECTRIMS & European Society for Blood and Marrow Transplantation. Game-changing treatment guidance!

🚀 Excited to share our latest Journal of Neurology publication on dreaMS app. Six gamified, adaptive cognitive tests (<10 min) improve sensitivity to change by addressing floor/ceiling & practice effects. Big thanks to our team & partners! Read more:

RT @MSJ_Research: Authors developed and validated SMARTCARE-EDSS training method to enable health care professionals to assess disability f…

🎉 First paper of 2025 is out! 🧠 "Aberrant complement activation is associated with structural brain damage" (Oechtering et al.) highlights the link between complement activation, brain volume loss, lesion progression, and severe MS. Read more: #RC2NB

🎉 Starting 2025 on a high note! Congrats to Dr. Andreea Alexandra Aldea on winning the YTCR grant for her study on choroid plexus volume in MS, mentored by Prof. Özgür Yaldizli. Backed by the @RC2NB & @ThINk_Basel teams, this project promises exciting insights! 🔬#MSresearch

On Dec 7, the MS Centre Basel @UniSpitalBasel & #RC2NB hosted “Learning from Patient Care for Research and Therapies.” A day filled with inspiring talks and lively exchanges during the apero & expert sessions. Thank you to all who joined and made this event a success! #MSresearch

Ending the Year on a High Note! Prof. @JensKuhle (@UniSpitalBasel) has been awarded the Sobek Foundation Award 2024, Europe’s most prestigious honor in MS research! A remarkable recognition for his work on biomarkers transforming MS care. @UniBasel_en #MultipleSclerosis

oin us this Saturday! 🌟 Be part of “Learning from Patient Care for Research & Therapies,” hosted by the MS Center & RC2NB. 📅 Dec 7, 2024 📍 ZLF, University Hospital Basel 🔹 Insights on MS research 🔹 Latest treatments 🔹 Community connections Check out the agenda below!

RC2NB researchers among the world's most cited! Congrats to Prof. @JensKuhle & Prof. Ludwig Kappos @lkappos1 from RC2NB & @UniSpitalBasel for being named Highly Cited Researchers in #Neuroscience & #Behaviour! 🧠 Your work inspires us all! Full list:

RT @cemcat_em: 🧠 Discover the latest advancements in MRI biomarkers for neuroimmunology in our upcoming session -

Proud to share that our PhD candidate, Yakine Raach won the *"Scientist-as-Filmmakers"* award at the 6th Global Science Film Festival! Her film *"Unusual Day"* captures a patient’s journey with MS-related fatigue. Watch it here: Congrats, Yakine! 🌟

Last week’s @RC2NB Scientific Advisory Board Meeting in Basel highlighted major progress in #MS research. Thanks to our speakers & team, our work and dedication were praised by the board! Basel’s unique research ecosystem was celebrated! @UniBasel_en @DKFBasel

Thrilled to announce our first Federated Learning proof of concept for MS is published! Huge thanks to the Clinnova team in Basel. Together, we're paving the way for data-driven, patient-centered healthcare across Europe! 🌍#Clinnova #FederatedLearning #MS

New research by Prof. @JensKuhle’s team @UniBasel_en @DKFBasel @RC2NB: 𝐬𝐆𝐅𝐀𝐏 signals 1.8x higher disease progression risk after 1 year. 𝐬𝐆𝐅𝐀𝐏 & 𝐬𝐍𝐟𝐋 reveal different MS aspects. Helps guide risk & treatment

RT @IJMSCtweets: "[R]epair and damage processes within [#MultipleSclerosis] #lesions occur across the entire disease spectrum and their fre…

New research on #Ocrelizumab reveals a manageable infection risk in patients with #MultipleSclerosis over long-term treatment. Kudos to the team, especially our very own Prof. Ludwig Kappos & Prof. Tobias Derfuss #MSresearch @UniSpitalBasel @UniBasel_en

Hot off the press! Our study, "Advanced MRI Measures of Myelin and Axon Volume Identify Repair in MS," is now published in Annals of Neurology! Congrats to @ThINk_Basel for leading this research in tracking MS lesion repair and damage with advanced MRI.